# Effect of dietary, pharmacological, and genetic topoisomerase ablation on Ph-like ALL risk in Hispanics

> **NIH NIH R37** · UNIVERSITY OF CALIFORNIA-IRVINE · 2022 · $59,674

## Abstract

The instructions from FOA PA-21-071 indicate that “At a minimum, the Research Strategy
section should be completed and must include a summary or abstract of the parent award or
project. Other sections should also be included if they are being changed by the proposed
supplement activities.”
The Project Summary/Abstract will not be changed as a result of the activities associated with
this supplement.

## Key facts

- **NIH application ID:** 10598405
- **Project number:** 3R37CA266042-01S1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA-IRVINE
- **Principal Investigator:** Nicholas Pannunzio
- **Activity code:** R37 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $59,674
- **Award type:** 3
- **Project period:** 2022-02-14 → 2027-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10598405

## Citation

> US National Institutes of Health, RePORTER application 10598405, Effect of dietary, pharmacological, and genetic topoisomerase ablation on Ph-like ALL risk in Hispanics (3R37CA266042-01S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10598405. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*